These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10078338)

  • 1. [Hypertrophic cardiomyopathy and physiologic hypertrophy in athletes: a new diagnostic approach using tissue color Doppler].
    Malergue MC
    Arch Mal Coeur Vaiss; 1999 Feb; 92(2):197-9. PubMed ID: 10078338
    [No Abstract]   [Full Text] [Related]  

  • 2. [Distinguishing between physiologic hypertrophy in athletes and primary hypertrophic cardiomyopathies. Importance of tissue color Doppler].
    Derumeaux G; Douillet R; Troniou A; Jamal F; Litzler PY; Pontier G; Cribier A
    Arch Mal Coeur Vaiss; 1999 Feb; 92(2):201-10. PubMed ID: 10078339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial stiffness and the timing difference between tissue Doppler imaging Ea and peak mitral valve opening can distinguish physiological hypertrophy in athletes from hypertrophic cardiomyopathy.
    King G; Foley JB; Royse CF; Yastrebov K; Hussey M; Boyle G; Bennet K; Cosgrave J; Crean P; Walsh M
    Eur J Echocardiogr; 2006 Dec; 7(6):423-9. PubMed ID: 16290130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Physiological versus pathological left ventricular remodeling in athletes].
    Quattrini FM; Pelliccia A
    G Ital Cardiol (Rome); 2012 Apr; 13(4):273-80. PubMed ID: 22495644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological and physiological left ventricular hypertrophy: echocardiography for differentiation.
    Chelliah RK; Senior R
    Future Cardiol; 2009 Sep; 5(5):495-502. PubMed ID: 19715413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A lethal pedigree of hypertrophic cardiomyopathy associated with mild left ventricular hypertrophy.
    Watson P; Burstow D; Stafford W
    Aust N Z J Med; 1996 Dec; 26(6):845-6. PubMed ID: 9028521
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.
    Basavarajaiah S; Wilson M; Whyte G; Shah A; McKenna W; Sharma S
    J Am Coll Cardiol; 2008 Mar; 51(10):1033-9. PubMed ID: 18325444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertrophic Cardiomyopathy, Athlete's Heart, or Both: A Case of Hypertrophic Cardiomyopathy Regression.
    Kebed KY; Bos JM; Anavekar NS; Mulvagh SL; Ackerman MJ; Ommen SR
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003312. PubMed ID: 26162782
    [No Abstract]   [Full Text] [Related]  

  • 9. Distinguishing hypertrophic cardiomyopathy from athlete's heart physiological remodelling: clinical significance, diagnostic strategies and implications for preparticipation screening.
    Maron BJ
    Br J Sports Med; 2009 Sep; 43(9):649-56. PubMed ID: 19734498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertrophic cardiomyopathy: from bedside to bench...and now back again?
    Ommen SR; Tajik AJ
    Circulation; 2001 Jul; 104(2):126-7. PubMed ID: 11447071
    [No Abstract]   [Full Text] [Related]  

  • 11. Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes.
    Vinereanu D; Florescu N; Sculthorpe N; Tweddel AC; Stephens MR; Fraser AG
    Am J Cardiol; 2001 Jul; 88(1):53-8. PubMed ID: 11423058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gray zone problem in athletes.
    Kasikcioglu E
    Eur Heart J; 2007 Oct; 28(19):2415-6. PubMed ID: 17670758
    [No Abstract]   [Full Text] [Related]  

  • 13. Athletes' heart and echocardiography: athletes' heart.
    Stout M
    Echocardiography; 2008 Aug; 25(7):749-54. PubMed ID: 18422671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe left ventricular wall thinning and extensive fibrosis without evolution to end stage disease in a patient with hypertrophic cardiomyopathy.
    Assenza GE; Spirito P; Musumeci MB; Lombardi M; Quarta G; Autore C
    J Am Soc Echocardiogr; 2009 Oct; 22(10):1196.e1-2. PubMed ID: 19801310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case records of the Massachusetts General Hospital. Case 26-2005. A 48-year-old man with sudden loss of consciousness while jogging.
    Binder WD; Fifer MA; King ME; Stone JR
    N Engl J Med; 2005 Aug; 353(8):824-32. PubMed ID: 16120863
    [No Abstract]   [Full Text] [Related]  

  • 16. Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy.
    Christiaans I; Lekanne dit Deprez RH; van Langen IM; Wilde AA
    Heart Rhythm; 2009 Sep; 6(9):1366-9. PubMed ID: 19539541
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening for hypertrophic cardiomyopathy in young athletes.
    Corrado D; Basso C; Schiavon M; Thiene G
    N Engl J Med; 1998 Aug; 339(6):364-9. PubMed ID: 9691102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple type of obstruction in hypertrophic cardiomyopathy.
    Efthimiadis GK; Parcharidou DG; Vassilikos V; Giannakoulas G; Pliakos C; Parcharidis GE
    J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1156-8. PubMed ID: 18852593
    [No Abstract]   [Full Text] [Related]  

  • 19. An approach to echocardiography in hypertrophic cardiomyopathy and other causes of LVH.
    Beadle R; Williams L
    Minerva Cardioangiol; 2012 Apr; 60(2):203-11. PubMed ID: 22495169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sports and Exercise in Athletes with Hypertrophic Cardiomyopathy.
    Alpert C; Day SM; Saberi S
    Clin Sports Med; 2015 Jul; 34(3):489-505. PubMed ID: 26100424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.